Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05141604

Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking

Monocular Visual Confusion for Field Expansion

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Massachusetts Eye and Ear Infirmary · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The investigators are developing a new test of pedestrian hazard detection in virtual reality (VR) head-mounted display (HMD) headset, which shows virtual oncoming pedestrians in 3D while subjects are walking in real-world environment, for evaluation of visual field expansion to improve mobility in people with visual field loss.

Detailed description

The investigators will develop a new pedestrian hazard detection test and conduct a single arm interventional clinical trial to evaluate simulated low vision assistive devices in a sample of field loss subjects. Pedestrian detection performance with and without field expansion information will be tested and compared. The study will include 1 to 4 visits (each 2 to 4 hours) depending on the number of trials and experimental conditions (e.g., with and without simulated assistive devices) the subject is comfortable completing. The time between visits may vary depending on scheduling constraints and availability. During each visit, the subject will complete a series of simulated collision avoidance trials in VR requiring the detection and natural avoidance of a colliding pedestrian (alongside non-colliding pedestrians) while physically walking through an empty corridor. The study will be considered minimal-risk since there will be no physical obstacles that present actual collision risks.

Conditions

Interventions

TypeNameDescription
OTHERField expansion viewOverlaid small window on HMD to show the part of the scene in the blind field into portions of the participants' remaining, seeing, field of vision

Timeline

Start date
2022-05-17
Primary completion
2026-03-30
Completion
2026-05-31
First posted
2021-12-02
Last updated
2025-10-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05141604. Inclusion in this directory is not an endorsement.